A study evaluating the pregnancy outcomes and safety of interrupting endocrine therapy for young women with endocrine responsive breast cancer who desire pregnancy (POSITIVE).
Olivia Pagani, MD (Oncology Institute of Southern Switzerland (IOSI))
Ann Partridge MD MPH (Dana-Farber Cancer Institute)
Hatem A. Azim Jr., MD, PhD (Institut Jules Bordet)
Fedro Peccatori, MD, PhD (European Institute of Oncology)